Progyny, Inc. declined 1.91% in after-hours trading. The company held a webinar on pelvic floor therapy, discussing its role in reproductive health, pregnancy, childbirth, and menopause. This event, while informative, may not have directly impacted the stock price, suggesting other factors could be at play.
Comments
No comments yet